Treatment of stage I lung cancer

Chest Surgery Clinics of North America

Volumn 11, Issue 1, 2001, Pages 17-38

  Walsh, G L ^a   Pisters, K M W ^a   Stevens, C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BCG VACCINE; CARBOPLATIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HYDROXYUREA; LEVAMISOLE; LOMUSTINE; MATRIX METALLOPROTEINASE INHIBITOR; METHOTREXATE; PACLITAXEL; UFT;

BONE SCINTISCANNING; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; GENE THERAPY; HUMAN; IMMUNOTHERAPY; LUNG CANCER; MEDIASTINOSCOPY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PHYSICIAN'S ROLE;

EID: 0035103177     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord
2. Effects of long-term adjuvant chemotherapy with cyclophosphamide for radically resected bronchogenic carcinoma
3. Results of surgical treatment of stage III lung cancer invading the mediastinum
4. CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method
5. Phase III trial of neo-adjuvant chemotherapy (NCT) in resectable stage I (except T1N0), II, IIIA non-small cell lung cancer (NSCLC): The French experience
6. Likelihood of malignancy in a solitary pulmonary nodule: Comparison of Bayesian analysis and results of FDG-PET scan
7. Local control in medical inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication
8. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer
9. Screening for lung cancer. A critique of the Mayo Lung Project
10. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma
11. Randomized trial of lobectomy versus limited resection for T1 N0 non - Small cell lung cancer. Lung Cancer Study Group
12. Fifteen-year follow-up of all patients in a study of postoperative chemotherapy for bronchial carcinoma
13. Video-assisted minithoracotomy versus muscle-sparing thoracotomy for performing lobectomy
14. Cancer statistics, 2000
15. Deep inspiration breath-hold technique for lung tumors: The potential value of target immobilization and reduced lung density in dose escalation
16. A simple cervico-mediastinal exploration for tissue diagnosis of intrathoracic disease. With comments on the recognition of inoperable carcinoma of the lung
17. Stage I non-small cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
18. Early lung cancer action project: Overall design and findings from baseline screening
19. Experience of the Verterans Administration surgical adjuvant group
20. Contemporary brachytherapy approaches in non-small-cell lung cancer
21. Intraoperative radiotherapy in stage I and II lung cancer
22. Present position relating to cancer of the lung: Results with radiation therapy alone
23. PET in oncology: Will it replace the other modalities?
24. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma
25. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)
26. The effectiveness of mediastinoscopy in the nodal staging of lung cancer
27. Detecting recurrent or residual lung cancer with FDG-PET
28. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer
29. Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography
30. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients
31. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
32. Lung cancer chemoprevention
33. Thoracoscopic lobectomy
34. A randomized controlled trial of postoperative adjuvant chemotherapy in non-small cell lung cancer
35. Prognostic factors in treatment of node negative non-small cell lung cancer with radiation therapy alone
36. Future diagnostic procedures
37. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy
38. Transthoracic fine needle aspiration biopsy. Sensitivity in relation to guidance technique and lesion size and location
39. The role of video-assisted thoracic surgery, for carcinoma of the lung: Wedge resection to lobectomy by simultaneous individual stapling
40. Solitary pulmonary nodule: Treatment options
41. Positron emission tomography in lung cancer
42. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
43. Results of surgical treatment in stage I lung cancer
44. Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer
45. Lobectomy by video-assisted thoracic surgery with mediastinal node sampling for lung cancer
46. Screening for early lung cancer. Results of the Memorial-Sloan Kettering study in New York
47. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
48. Revisions in the international system for staging lung cancer
49. Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population
50. Prognosis and survival in resected lung carcinoma based on the new international staging system
51. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study
52. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized trials
53. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer
54. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study
55. Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team
56. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
57. Controlled prospective study of positron emission tomography using the glucose and analogue 18f fluorodeoxyglucose in the evaluation of pulmonary nodules
58. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: A 7-year assessment of a randomized controlled trial
59. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
60. Video-assisted thoracoscopic surgery (VATS) major pulmonary resections: The Italian experience
61. Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung
62. Radiotherapy for patients with medically inoperable stage I non-small cell lung carcinoma: Smaller volumes and higher doses - A review
63. Bronchogenic carcinoma. Nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project
64. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer
65. Can lung cancer be cured by radiation therapy alone?
66. Lung tumor motion with respiration does not correlate with location, pulmonary function or chest wall motion
67. Measuring effectiveness of lung cancer screening: From consensus to controversy and back
68. Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction
69. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: A prospective analysis
70. Adjuvant chemotherapy after complete resection in non-small cell lung cancer
71. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption
72. The use of active breathing control (ABC) to reduce margin for breathing motion